Immediate Release Pain Management to 2020


Chart_Collage_160    Published May 2014  •  Catalog no. PMP492R  •  Price US $3,850



As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to alternative formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transmucosal immediate release pain management addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. We expect this market to experience healthy growth through 2020 as absorbable solid dosage technology is applied to existing drugs, and as similar formulations become an important route of administration for novel pain drugs. Immediate Release Pain Management to 2020 is a comprehensive analysis of this evolving product segment.

Bar_GraphImmediate Release Pain Management – Report Prospectus (Download PDF)

Blue document Immediate Release Pain Management Report Order Form (Download PDF)


Highlights

· Analyzes and evaluates the global market opportunity for immediate release pain management and assesses the probable impact of evolving regulatory, economic and demand factors

· Assesses immediate release products approved or in development for the delivery of therapeutic pain management drugs

· Provides detailed descriptions of pain management treatment segments, market factors, and business strategies

· Forecasts immediate release pain management product demand to 2020

· Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners


Summary of Contents

Executive Summary

The Pain Management Market

Evolving Pain Management Protocols
Demographics and Disease
Regional Differences in Pain Management
Immediate Release Pain Management
Breakthrough Cancer Pain
The Current Landscape
The Unmet Need and Opportunity

Immediate Release Formulation Technologies

Buccal Films and Tablets
Oral Sprays
Sublingual Tablets
Nasal Sprays

The Market for Breakthrough Cancer Pain

The Addressable Market
Market Demographics and Growth
Competing Drug Classes
Market Projections

Product Analysis, Market Position Historical Revenue & Forecasts

Transmucosal Immediate-Release Fentanyl (TIRF)
Oral
Abstral
Actiq
Fentora/Effentora
Onsolis/Breakyl
Subsys
Generic Immediate Release Fentanyl
Nasal
Instanyl
Lazanda

Development-Stage IR Pain Management Drugs

Alfentanil
Sufentanil
Potential Competing Drug Therapeutics

Market Factors

Regulatory Factors
Proprietary Formulations & Technology
Collaborations & Alliances

Company Profiles